Renew Biotechnologies
May 21, 2024
Renew BioTechnologies is dedicated to exploring and embracing groundbreaking biotechnologies and intellectual property. With a remarkable knack for capturing market share, Renew excels in leveraging its cutting-edge technologies and spearheads innovation in the field. Renowned for its strategic alliances and sponsored research agreements with leading universities, Renew consistently enjoys a robust pipeline of exciting new biotech projects, propelling the frontiers of scientific progress.
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
